FDA Inspection
Cytovance Biologics Inc.Cytovance Biologics Inc. – FDA Inspection, May 9, 2019
Record Details
This FDA Inspection record concerns Cytovance Biologics Inc., with an inspection on May 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d6179c1f-7a2a-4cce-9010-40bb23f19661
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1089182
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cytovance Biologics Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2026 | Not classified | Dallas District Office | |
| April 27, 2018 | Not classified | Dallas District Office | |
| July 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cytovance Biologics Inc.
- FDA Inspection 1322570 - 2026-06-17
- FDA Inspection 1078729 - 2018-04-27
- FDA Inspection 1026556 - 2017-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.